Some lightly updated reports produced lately by the Congressional Research Service include the following.
Direct Overt U.S. Aid Appropriations for and Military Reimbursements to Pakistan, FY2002-FY2014, April 11, 2013
Sensitive Covert Action Notifications: Oversight Options for Congress, April 10, 2013
Covert Action: Legislative Background and Possible Policy Questions, April 10, 2013
Navy Ship Names: Background For Congress, April 8, 2013
Navy Littoral Combat Ship (LCS) Program: Background and Issues for Congress, April 5, 2013
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.